Concepedia

Melanie S. Glossop

MS

Statistics

Publications

6

Citations

120

H-Index

6

Active since

2009

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

Melanie S. Glossop is an author at Pfizer (United Kingdom) specializing in drug discovery, chemical biology, and natural sciences.

Top concepts

Publications per year

2009–2023

6

Publications

6

Discovery and Optimization of Selective Na <sub>v</sub> 1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of Pain

Sharan K. Bagal, Peter J. Bungay, Stephen M. Denton et al. · ACS Medicinal Chemistry Letters · 2015 · 40 citations · Full text

Optimisation of Permanganate Oxidation and Suzuki−Miyaura Coupling Steps in the Synthesis of a Na<sub>v</sub>1.8 Sodium Channel Modulator

M. Jonathan Fray, Adam T. Gillmore, Melanie S. Glossop et al. · Organic Process Research & Development · 2009 · 21 citations

AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models

Stephen M. Shaw, Jenny Middleton, Kim Wigglesworth et al. · Cancer Cell International · 2019 · 16 citations · Full text

Disulfide re-bridging reagents for single-payload antibody-drug conjugates

Thomas A. King, Stephen J. Walsh, Mia Kapun et al. · Chemical Communications · 2023 · 16 citations · Full text

Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitors

Melanie S. Glossop, Richard Bazin, Kevin N. Dack et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 15 citations · Full text

, , +7

1–5 of 6